Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |